Nitto Avecia
Jackie Puglisi is an accomplished Process Development Principal Validation Scientist with extensive experience in the biopharmaceutical industry, currently employed at Nitto Avecia since January 2007. Prior experience includes a tenure as a Senior Process Chemist at Avecia until March 2022, and as a Senior Process Development Associate at Shire Biologics from 1999 to November 2006, where responsibilities included developing and scaling biological processes for Pilot Plant transfer, focusing on recombinant proteins and viruses. Jackie has also held various process development associate roles at Biochem Pharma, ID Biomedical, GSK, as well as a position as Process Engineer III at Genzyme, and a process development associate role at Hybridon, showcasing a diverse background in process development spanning over two decades. Education was completed at Saint Joseph's College between 1986 and 1990.
This person is not in the org chart
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.